Paper2001981
Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells.
Omura S and 6 others. J Antibiot (Tokyo), 1991. Cited by 217 papers, by iCite.
Cite this record
ConductScience Library. Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. Papers, record 2001981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2001981
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Neurons | Major topic |
| Acetylcysteine | |
| Cell Differentiation | |
| Magnetic Resonance Spectroscopy | |
| Molecular Conformation | |
| Molecular Structure | |
| Neuroblastoma | |
| Streptomyces | |
| Tumor Cells, Cultured | |
| X-Ray Diffraction |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 217 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41220833 | Synthetic study toward vibralactone. | Beilstein J Org Chem | 2025 | https://conductscience.org/library/papers/41220833 | PubMed |
| 40874681 | Nickel-Catalyzed Carbonylative Cyclization of Bromodifluoroacetamides with Arylboronic Acids toward δ-Lactams. | Org Lett | 2025 | https://conductscience.org/library/papers/40874681 | PubMed |
| 40819216 | Ubiquitination dynamics in human tumour viruses: Viral infection, oncogenesis and antiviral therapy. | FEBS J | 2026 | https://conductscience.org/library/papers/40819216 | PubMed |
| 39806036 | Biosynthesis of lactacystin as a proteasome inhibitor. | Commun Chem | 2025 | https://conductscience.org/library/papers/39806036 | PubMed |
| 38784729 | Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation. | Chem Sci | 2024 | https://conductscience.org/library/papers/38784729 | PubMed |
| 36173301 | Host Cell Neddylation Facilitates Alphaherpesvirus Entry in a Virus-Specific and Cell-Dependent Manner. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/36173301 | PubMed |
| 35531531 | Formal synthesis of (+)-lactacystin from l-serine. | RSC Adv | 2019 | https://conductscience.org/library/papers/35531531 | PubMed |
| 34767710 | Enzymatic Cβ-H Functionalization of l-Arg and l-Leu in Nonribosomally Derived Peptidyl Natural Products: A Tale of Two Oxidoreductases. | J Am Chem Soc | 2021 | https://conductscience.org/library/papers/34767710 | PubMed |
| 33791679 | Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors. | RSC Chem Biol | 2020 | https://conductscience.org/library/papers/33791679 | PubMed |
| 31936021 | Screening for Sulfur Compounds by Molybdenum-Catalyzed Oxidation Combined with Liquid Chromatography-Mass Spectrometry. | Molecules | 2020 | https://conductscience.org/library/papers/31936021 | PubMed |
| 30755736 | Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research. | J Antibiot (Tokyo) | 2019 | https://conductscience.org/library/papers/30755736 | PubMed |
| 30029468 | (-)-Homosalinosporamide A and Its Mode of Proteasome Inhibition: An X-ray Crystallographic Study. | Mar Drugs | 2018 | https://conductscience.org/library/papers/30029468 | PubMed |
| 28196975 | Tyropeptins, proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/28196975 | PubMed |
| 25730728 | The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery. | Nat Prod Rep | 2015 | https://conductscience.org/library/papers/25730728 | PubMed |
| 25491896 | Streptomyces lactacystinicus sp. nov. and Streptomyces cyslabdanicus sp. nov., producing lactacystin and cyslabdan, respectively. | J Antibiot (Tokyo) | 2015 | https://conductscience.org/library/papers/25491896 | PubMed |
| 24784133 | Natural compounds as next-generation herbicides. | Plant Physiol | 2014 | https://conductscience.org/library/papers/24784133 | PubMed |
| 24353244 | Neurotrophic natural products: chemistry and biology. | Angew Chem Int Ed Engl | 2014 | https://conductscience.org/library/papers/24353244 | PubMed |
| 23181572 | From bortezomib to other inhibitors of the proteasome and beyond. | Curr Pharm Des | 2013 | https://conductscience.org/library/papers/23181572 | PubMed |
| 22021939 | Sporolide B: Synthetic Studies. | Tetrahedron | 2011 | https://conductscience.org/library/papers/22021939 | PubMed |
| 21916437 | Stereospecific total syntheses of proteasome inhibitors omuralide and lactacystin. | J Org Chem | 2011 | https://conductscience.org/library/papers/21916437 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2001981
GET https://conductscience.org/api/papers/v1/2001981/cited_by?page=2